Omnia Holdings Limited

Omnia is a 73-year-old South African industrial chemicals group that has repositioned itself as a two-engine primary-sector supplier: crop nutrition (Agriculture) and mining explosives and metallurgical chemicals (Mining, under the BME brand). Both engines are underpinned by the Sasolburg nitric-acid and ammonium-nitrate complex, one of the largest in the SADC region. The group has been rebuilt since its 2019 recapitalisation from a debt-stressed conglomerate into a net-cash, high-payout business. In FY26 it reported R24.2 billion revenue, a 9.0% operating margin and R1.68 billion net cash excluding leases. Its differentiators are its integrated ammonia-derivative supply chain, the Nutriology® agronomy model, AXXIS™ electronic initiation, and a growing international mining footprint in Indonesia, Canada and Australia. The legacy Chemicals segment has been largely exited. On 14 September 2026 the board agreed to recommend a R21.8 billion cash takeover by India's Solar Industries. Omnia is therefore now best analysed as a pending-take-private situation backed by strong standalone fundamentals.

Company's own description

In its FY26 results, Omnia describes itself as a diversified chemicals group supplying chemicals, specialised services and solutions to the agriculture, mining and chemicals application industries [FY26-LF]. It says it combines technical innovation with intellectual capital to add value across the supply and service chain. It also says its solutions promote the responsible use of chemicals and are shifting towards cleaner technologies. The group's stated purpose is "innovating to enhance life, together creating a greener future" [IAR26].

The company groups its activities into three reporting industries: Agriculture, Mining and Chemicals. These are supported by a shared Manufacturing and Supply Chain capability centred on Sasolburg [FY26-LF].

Independent characterisation

Economically, Omnia is a vertically integrated nitrogen-chemistry platform with two value-added downstream channels.

Upstream. Omnia buys ammonia, historically mainly from a key domestic supplier that underwent extended shutdowns in FY26, and phosphate rock. At Sasolburg it converts these into:

• nitric acid

• ammonium nitrate (AN) solution

• porous granular and prilled AN

• ANCN dual salt and calcium nitrate

• nitrophosphate-derived intermediates

• granulated NPK fertilizers

Downstream channel 1: Agriculture. Product is sold through a technical-advisory model (Nutriology®) to commercial and small-scale farmers, cooperatives and governments in South Africa and the Rest of Africa. Internationally, the group sells higher-margin biostimulants (humates, fulvates, kelp, microbials) from Australia, Brazil and the USA.

Downstream channel 2: Mining (BME). AN feeds bulk emulsion explosives, which are delivered by mobile manufacturing units and bundled with AXXIS™ electronic detonators, blast-design software and on-bench services. BME Metallurgy supplies flotation, solvent-extraction and ammonia-derivative reagents to mineral processors.

Residual: Chemicals. After the FY25–FY26 restructuring, this is a Bulk Trade business that monetises the group's ammonia-derivative and bulk-liquid logistics, plus a Water Care business that is held for sale.

The economic logic. The integrated asset base lets Omnia allocate scarce AN between agriculture (seasonal) and mining (year-round). It secures supply when competitors face force majeure, and it earns margin on third-party ammonia-derivative sales. These points recur in every results commentary from FY23 to FY26.

Revenue model

Omnia is overwhelmingly a product business. It has no disclosed subscription or licensing revenue. Software and AXXIS™ technology are bundled into blasting contracts, and part of Mining RSA revenue is cost recovery for services and technology [FY26-LF].

Sources: [FY23-LF] for FY22–FY23; [FY25-LF] for FY24–FY25; [FY26-LF] for FY26.

In FY26, services were most significant in Mining: R601 million of R9,816 million Mining revenue, or 6.1%. This reflects BME's blasting-services content [FY26-LF].

Value-chain position, customers and end markets

Source: [FY26-LF]; [IAR26].

Stated strategy (IAR 2026)

The strategy is to grow and diversify the business geographically, built on existing strengths and disciplined capital allocation [IAR26].

Four strategic priorities:

1. Build a safety-first culture and invest in our people.

2. Protect and grow our core (SADC).

3. Create a global mining solutions business of scale.

4. Deliver sustainable solutions to global biostimulant markets.

Five strategic drivers: purpose and values; high-performance culture; sustainability principles; technology and innovation; disciplined capital allocation.

Delivery levers: maintain disciplined capital allocation; optimise the operating model; prioritise people and culture; enhance stakeholder collaboration.

The "global mining solutions" pillar explicitly includes exploring M&A potential to unlock value and scale. The Solar transaction can be read as the culmination of this pillar, delivered by sale rather than acquisition [IAR26].

Pricing models for individual products are not publicly disclosed. FY23 commentary confirms that Mining contracts include contractual pass-through of ammonia price movements [FY23-LF]. Launch dates are given where disclosed; otherwise "n/d".

Basis. IFRS, ZAR million, years ended 31 March. FY22 figures are from continuing operations; FY22 total profit including discontinued Umongo was R1,353m. FY22–FY23 include Zimbabwe under IAS 29 hyperinflation accounting.

Sources: FY22 comparatives and FY23 from [FY23-LF]; FY24 from [FY25-LF] comparatives; FY25–FY26 from [FY26-LF].

Income statement

Notes:

• FY22 basic EPS including discontinued operations was 811c.

• FY23 operating profit is after a R160m net hyperinflation/FX loss and a R90m loss on the Zimbabwe JV disposal.

• FY23 "adjusted" (ex-Zimbabwe) HEPS was 739c.

Commentary. The five-year revenue line is dominated by the commodity cycle, not volume. FY23 revenue jumped 24% to R26.6bn on elevated post-Ukraine ammonia and urea prices. It then fell 16% in FY24 when prices collapsed [FY23-LF]; [FY24-SF].

Operating profit has been far more stable than revenue, at R1.6–1.9bn in FY22–FY25. This shows that management priced to protect margin and security of supply rather than chasing commodity revenue.

The FY26 inflection is the first year since the turnaround in which operating profit broke decisively above R2bn and the operating margin moved into the upper half of the 8–10% medium-term range. Three drivers explain it:

1. A R322m swing in Agriculture Rest of Africa, partly FX-driven.

2. A R137m swing in Chemicals as the loss-making product lines were exited.

3. A R49m reduction in head-office costs [FY26-LF].

Gross margin is structurally about 22%. The FY23 dip to 19.6% reflects inventory-cost lag during the Q4 FY23 price collapse.

The effective tax rate is persistently above the 27% statutory rate. FY26 reconciliation items include:

• non-deductible expenses (4.7 points)

• unrecognised tax losses (1.7 points)

• withholding tax (1.4 points)

• a modest IFRIC 23 effect [FY26-LF]

The SARS transfer-pricing dispute keeps the tax line uncertain.

Balance sheet

Note: company-reported net cash excludes supply-chain-finance payables. FY23 short-term borrowings include a R266m overdraft.

Commentary. Omnia has been net cash every year since FY21. Interest-bearing borrowings were only R150m at FY26.

The analyst should treat the Standard Bank supply-chain-finance facility as quasi-debt:

• Facility size: R1,980m. Utilisation: R1,317m.

• R701m of the utilised balance has a finance element and is shown separately on the balance sheet [FY26-LF].

• Including it, the adjusted FY26 net cash position falls to about R0.5bn including leases (derived).

Goodwill and intangibles have run down from R278m to R14m. Acquisition intangibles have been fully amortised or impaired, and the group's acquisition history no longer burdens the balance sheet.

Net working capital rose R325m in FY26. Management attributes this to strong Q4 sales receivables and precautionary inventory amid supplier and Middle East uncertainty. The working-capital-to-revenue ratio was 15.5% versus 15.0% in FY25 [FY26-LF].

Cash flow

Note: FY22–FY23 "cash from operations excluding working capital" is not reported on a comparable basis, so 0 is shown as a placeholder for "not disclosed". FY22 investing inflows include R958m of Umongo disposal proceeds.

Critical analytical point. Reported operating cash flow is materially flattered by the supply-chain-finance structure. When a supplier invoice is factored through the facility, Omnia treats it as a non-cash transaction. The eventual cash settlement is classified as a financing outflow, not an operating one [FY26-LF].

As a result, reported OCF rose from R1.4bn (FY22) to R4.8bn (FY26). Adjusted free cash flow after supply-chain-finance repayments has been broadly stable at R0.7–1.7bn. In FY26 it was R1.06bn, against dividends paid of R1.09bn.

Distributions are therefore broadly covered by genuine cash generation. The "R4bn FCF" headline sometimes derived from the cash-flow statement should be avoided.

Ratios

Methodology notes:

• FY22 ROE uses total attributable profit including discontinued operations; on continuing operations it is 11.1%.

• ROIC = operating profit × (1 – effective tax rate) ÷ (equity + borrowings + leases + supply-chain finance – cash).

• Days payables use total trade and other payables, which include some non-trade items.

• Company covenant metrics differ: interest cover was 23x and net debt/adjusted EBITDA (0.43) in FY26; 26x and (0.53) in FY25 [FY26-LF]; [FY25-LF].

Commentary. Returns are adequate rather than exceptional at the group level. ROE of 11–14% is held down by structurally high cash and NWC balances and a sub-scale Chemicals tail. It is masked by Mining's 36% return on net-controlled assets.

The FY26 step-up in ROIC to 14% and RONCA to 22% is the clearest evidence that the Chemicals exit and Rest of Africa recovery are improving capital productivity. The cash conversion cycle is remarkably stable at 63–67 days despite large commodity-price swings, which reflects disciplined working-capital management.

Leverage is negligible. The covenants (net debt/adjusted EBITDA below 3x; interest cover above 4x) are nowhere near binding [FY26-LF].

Half-year datapoints

Source: [HY26] and Business Report / IOL (10 November 2025). HY25 Mining and Agriculture figures are back-solved from the reported HY26 growth rates (Mining revenue +3%, operating profit +7%; Agriculture revenue +11%, operating profit +9%) and are therefore approximate.

The interim results for the six months to 30 September 2026 (HY27) are scheduled for 9 November 2026 [AGM26].

Management guidance (qualitative)

Management expects a volatile FY27 shaped by the Middle East conflict and supply disruption, while remaining confident in growth [FY26-LF]:

Agriculture: sustainable earnings from speciality products and SADC share gains. South Africa is expected to be more volatile, with pressure on farmer affordability. Rest of Africa should expand its retail and distribution footprint. Agriculture International should grow.

Mining: positive in South Africa despite sector pressure. Robust SADC demand (copper, uranium, battery minerals). Selective repositioning in West Africa. Indonesia diversifying into metals. Australian in-country detonators. HPE commercialisation in North America.

Chemicals: further disposals and scaling of Bulk Trade.

No numeric earnings guidance is given. Consensus growth expectations are not publicly disclosed. Simply Wall St's narrative model (2025) assumed about 6.7% revenue growth per year, which is aggregator-derived and stale.

Bull case

1. Deal certainty with a full price. R134.50 equals about 15.8x FY26 HEPS and 7.2x EV/EBITDA. That is a 35.7% premium to the 30-day VWAP and 71% above the 31 December 2025 price, for a business whose adjusted free cash flow (about R1.06bn) roughly matches its dividends. Bank-guaranteed cash and about 20% early support reduce execution risk.

2. Standalone earnings power is rising. FY26 operating profit grew 28% with Chemicals at breakeven. A full year of Australian detonator production, Canadian approvals and HPE could restore Mining International to its FY25 12.9% margin.

3. Balance-sheet optionality. Net cash, GCR A+ and minimal debt would support re-leveraging or continued special dividends if the deal lapses, putting a floor under value.

Bear case

1. Competition and regulatory risk. Solar already competes in South Africa through Problast and its Middelburg plant. A horizontal overlap with BME, alongside public-interest and B-BBEE conditions, could delay the deal past the 31 July 2027 longstop or require remedies. If the deal fails, the price could revert towards the undisturbed level of about R100.

2. Input-cost shock. Post-year-end Middle East disruption raises ammonia, freight and insurance costs and working capital. With Agriculture RSA already down to an 8.9% margin from supplier shutdowns, H1 FY27 (due 9 November 2026) could disappoint.

3. Quality-of-earnings caveats. The FY26 improvement relied partly on Zambian FX gains (R179m in Agriculture Rest of Africa) and on Chemicals loss elimination. Mining margins fell. The SARS exposure (interest alone about R573m) remains open.

Analyst verdict

Omnia enters the final phase of its life as a listed company in the best operational and financial shape since its 2019 near-failure. Seven years after a distressed R20 rights issue, the group earns R2.2 billion of operating profit at a 9% margin and holds net cash. It has exited a structurally unprofitable chemicals distribution business and built credible footholds in Indonesia, Canada and Australia for its BME mining franchise.

The FY26 numbers deserve some scrutiny. Reported operating cash flow is inflated by supply-chain-finance classification. Part of the Rest of Africa recovery came from FX gains. Mining margins slipped while international businesses were still in mobilisation. On a clean basis, Omnia is a business generating roughly R1–1.1 billion of genuine annual free cash flow on about R10.8 billion of equity. It is cash-generative and well run, but its group returns are low-teens rather than exceptional.

Against that baseline, Solar's R134.50 cash offer looks full and well timed for shareholders. It capitalises FY26 peak-cycle earnings at about 16x HEPS and 7x EV/EBITDA, roughly a 35% premium to the pre-approach trading range. It also transfers the costs of the international build-out, the Middle East feedstock shock and the SARS dispute to the buyer.

Solar's strategic logic is coherent. AXXIS™, integrated ammonium nitrate and an African mining distribution network fill gaps in Solar's footprint. The acquirer's own investors, however, have questioned the leverage.

The investment debate has therefore shifted from fundamentals to completion. The principal risk is regulatory: a horizontal South African explosives overlap with Solar's Problast must clear competition authorities before 31 July 2027. Our view is that the offer is fair to modestly generous on standalone fundamentals. Holders should weigh time value and regulatory risk against the strongly supported scheme, and monitor the fairness opinion, the competition filings and the 9 November 2026 interim results as the decisive near-term signposts.

Source register (primary URLs)

• FY26 long-form results: https://omnia.co.za/media/omnia-annual-financial-results-long-form-fy2026.pdf

• FY25 long-form results: https://omnia.co.za/media/omnia-annual-financial-results-long-form-FY2025.pdf

• FY24 short-form results (SENS): https://senspdf.jse.co.za/documents/SENS_20240610_S490589.pdf

• FY23 results: https://senspdf.jse.co.za/documents/2023/JSE/ISSE/OMN/FY23.pdf

• FY22 results press release: https://omnia.co.za/posts/omnia-annual-results-20-june-2022

• Integrated Annual Report 2026: https://www.omnia.co.za/media/integrated-annual-report-2026.pdf

• Notice of AGM 2026: https://www.omnia.co.za/media/notice-of-meeting-2026.pdf

• HY26 results release: https://www.omnia.co.za/posts/hy26-financial-results

• SENS, PIC 20.520% (15 May 2026): https://sharedata.co.za/sens.asp?id=547863

• SENS, company secretary (2 Mar 2026): https://sharedata.co.za/v2/scripts/SENS.aspx?id=540499

• SENS, trading statement FY26 (25 May 2026): https://sharedata.co.za/sens.asp?id=548728

• Deal coverage, Engineering News: https://www.engineeringnews.co.za/article/omnia-receives-r218bn-buyout-bid-from-india-headquartered-group-2026-09-14

• Deal coverage, BusinessDay: https://www.businessday.co.za/companies/2026-09-15-solars-r22bn-omnia-bid-signals-confidence-in-sa-industry/

• Deal coverage, MiningMX: https://www.miningmx.com/news/markets/67260-omnia-to-recommend-r21-5bn-buyout-from-indias-solar/

• Deal coverage, MiningMX interview: https://www.miningmx.com/news/markets/67301-is-solar-an-optimum-outcome-for-omnia/

• Deal coverage, BusinessTech: https://businesstech.co.za/news/business/875226/end-of-a-46-year-era-for-r22-billion-mining-and-agriculture-giant-in-south-africa/

• Solar market reaction, Moneylife: https://www.moneylife.in/article/solar-industries-shares-plunge-136-percentage-as-14-billion-omnia-deal-sparks-leverage-concerns/81661.html

• AECI FY2025 results: https://investor.aeciworld.com/pdf/annual-results/2025/sens.pdf

• Orica FY2025 results: https://clients3.weblink.com.au/pdf/ORI/03022371.pdf

• 2019 recapitalisation, Engineering News: https://www.engineeringnews.co.za/article/omnia-seeks-to-reset-course-as-it-emerges-from-financial-distress-2019-10-11

• BME history, GBR interview: https://www.gbreports.com/interview/ralf-hennecke

• Ownership aggregator, Simply Wall St: https://simplywall.st/stocks/za/materials/jse-omn/omnia-holdings-shares/ownership

• Market sizing, biostimulants (GMI): https://www.gminsights.com/industry-analysis/biostimulants-market

• Market sizing, biostimulants (Dunham Trimmer via AgroSpectrum): https://agrospectrumindia.com/news/88/32961/global-biostimulant-market-reaches-4-47-bn-as-industry-signals-maturity.html

• Market sizing, South African fertilizer (Ken Research): https://www.kenresearch.com/industry-reports/south-africa-fertilizer-crop-nutrition-market

• Market sizing, explosives (GMI): https://www.gminsights.com/industry-analysis/explosives-and-pyrotechnics-market/amp

11 minutes ago

Approaching weekly limit